With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and ...

The recent acquisition of LifeLabs is a testament to Quest's aggressive expansion strategy. Quest Diagnostics reported an impressive increase in revenue and profit metrics during the fourth quarter.

Quest Diagnostics DGX recently announced a strategic ... providers worldwide through its Global Diagnostic Network. This expansion will not only benefit provider customers but also advance the ...

(RTTNews) - Quest Diagnostics (DGX) reaffirmed its guidance for full year 2025. The company continues to project: adjusted EPS in a range of $9.55 to $9.80, and net revenues in a range of $10.70 ...

Quest Diagnostics adjusts Q1 revenue & EPS outlook due to weather impact, projects 4-5% CAGR revenue growth beyond 2025. Read ...

The Quest Diagnostics office, at 1074 Idaho St., will have two phlebotomists when fully staffed and expects to draw blood ...

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive ...

Quest Diagnostics announced it is teaming up with Google Cloud to develop artificial intelligence programs that can ...

With a market cap of $18.5 billion, Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services in the United States and internationally. It operates through two ...

The collaboration between Quest and Google Cloud is the latest example of the use of AI agents in healthcare to automate ...